Stock Events

Stock Events

Werewolf Therapeutics 

$0.79
0
+$0.03+4.62% Tuesday 04:00

Statistics

Day High
0.79
Day Low
0.79
52W High
-
52W Low
-
Volume
5,620
Avg. Volume
-
Mkt Cap
38.11M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2025
Next
-0.38
-0.35
-0.31
-0.27
Expected EPS
-0.27
Actual EPS
N/A

Financials

-3,740.85%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
3.77MRevenue
-141.03MNet Income

Analyst Ratings

$5.50Average Price Target
The highest estimate is 7.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HOWL.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a leading biopharmaceutical company that competes in the oncology space, directly challenging Werewolf Therapeutics' cancer immunotherapy approaches.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that develops immunotherapy treatments for cancer, competing with Werewolf Therapeutics' innovative therapies.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. focuses on the development of drugs for cancer treatment, making it a competitor in the oncology market alongside Werewolf Therapeutics.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. is a biotechnology company engaged in the discovery of novel cancer treatments, competing with Werewolf Therapeutics in the biopharmaceutical sector.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals, Inc. is involved in the development of cancer immunotherapies, directly competing with Werewolf Therapeutics' focus on modulating the immune system to fight cancer.
Novartis
NVS
Mkt Cap237.61B
Novartis AG is a healthcare company that offers a range of cancer treatments, including immunotherapies that compete with Werewolf Therapeutics' product pipeline.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a global pharmaceutical corporation with a strong presence in the oncology market, making it a competitor to Werewolf Therapeutics.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a major player in the development of cancer treatments, including immunotherapies that rival Werewolf Therapeutics' approaches.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC is a biopharmaceutical company focusing on the development of cancer therapies, competing with Werewolf Therapeutics in the oncology sector.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a diversified healthcare company that develops and markets cancer treatments, competing with Werewolf Therapeutics in the pharmaceutical and biotechnology industry.

About

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
ISIN
US95075A1079

Listings

XNAS
US
HOWL
BOATS
BOATS
HOWL.BOATS

0 Comments

Share your thoughts

FAQ

What is Werewolf Therapeutics stock price today?▼
The current price of HOWL.BOATS is $0.79 USD — it has increased by +4.62% in the past 24 hours. Watch Werewolf Therapeutics stock price performance more closely on the chart.
What is Werewolf Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Werewolf Therapeutics stocks are traded under the ticker HOWL.BOATS.
What is Werewolf Therapeutics market cap?▼
Today Werewolf Therapeutics has the market capitalization of 38.11M
When is the next Werewolf Therapeutics earnings date?▼
Werewolf Therapeutics is going to release the next earnings report on May 07, 2026.
What were Werewolf Therapeutics earnings last quarter?▼
HOWL.BOATS earnings for the last quarter are -0.36 USD per share, whereas the estimation was -0.38 USD resulting in a +6.09% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Werewolf Therapeutics revenue for the last year?▼
Werewolf Therapeutics revenue for the last year amounts to 3.77M USD.
What is Werewolf Therapeutics net income for the last year?▼
HOWL.BOATS net income for the last year is -141.03M USD.
When did Werewolf Therapeutics complete a stock split?▼
Werewolf Therapeutics has not had any recent stock splits.